Clinical Trials | May 20, 2022
Motilal Oswal Private Equity (MOPE) invests in Pathkind Diagnostics
A primary investment of Rs 194.4 crore has been made
A primary investment of Rs 194.4 crore has been made
The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube
With the approval from the Central Drugs Standard Control Organisation (CDSCO), Jardiance is now the first approved therapy to improve outcomes for the full spectrum of heart failure regardless of ejection fraction
The latest certification endorses product for cold chain monitoring across 194 WHO member countries
The centres will be located in Tier I and Tier II cities
The curriculum has been curated for General Physicians working in Clinikk
Surgical treatment of chronic pancreatitis is challenging in children and especially laparoscopic surgery has been rarely reported, worldwide
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
Multiples is the first private equity (PE) investor in the company
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Subscribe To Our Newsletter & Stay Updated
